Day Traders Tag icon

×
Tuesday, Trinity Biotech plc (NASDAQ:TRIB) stock is trading higher with a session volume of 14.32 million versus the average volume of 118.9K as per data from Benzinga Pro. The company received substantial additional orders for TrinScreen HIV. Due to this demand and the scaling of production capacity, the company is now increasing its expected 2024 sales revenue for TrinScreen HIV to approximately $10 million, up from $8 million. President and Chief Executive Officer of Trinity Biotech, John Gillard, said, “We are pleased to have scaled up our manufacturing capacity to meet the increased demand for TrinScreen HIV.  Also, as a company with a strong presence in infectious disease, we have also increased our manufacturing capacity ...


In The news